Top 23 Erasca investors
The most complete profiles first. Showing 23 of 23.
Carol SuhVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
David BonitaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more
Verified email available
David CruikshankVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHardwarePortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Geoffrey HsuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan LimVerified
Venture Capital, Private Equity Firm, Finance Operator · United States
Series BHealth CareWomen FoundedEnterprise SoftwareTransportationPortfolio: Black Diamond Therapeutics, Ignyta, Flex Pharma, Independa and 6 more
Verified email available
Sean KendallVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareEnterprise SoftwareEnergyChemicalPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Jonathan SilversteinVerified
Private Equity Firm · United States
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WangVerified
Private Equity Firm · China
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Mark McDonnellVerified
Venture Capital · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Rishi GuptaVerified
Private Equity Firm · United States
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Tom BrennanVerified
Venture Capital, Private Equity Firm · United States
Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Carter Neild
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Chau Khuong
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more
Contact details available
Corey Ritter
Venture Capital, Investor · United States
Series BHealth CareLife ScienceRoboticsManufacturingPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Nilay Thakar
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Scotland Stevens
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Steve Gillis
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more
Contact details available
Jorge CondeVerified
Venture Capital, Private Equity Firm, Finance Operator · United States
Series BSeries APaymentsCybersecurityWomen FoundedEnterprise SoftwarePortfolio: Tmunity Therapeutics, Eco, Vicinitas Therapeutics, EQRx and 2 more
Verified email available
Anat Naschitz
Private Equity Firm · Israel
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Erez Chimovits
Private Equity Firm · Israel
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Robert Nelsen
Venture Capital, Investor · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more
Contact details available
Sundeep AgrawalVerified
Private Equity Firm · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Ignyta, Silverback Therapeutics, Erasca, ReCode Therapeutics and 1 more
Verified email available
Darren Blanton
Private Equity Firm · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Ignyta, Silverback Therapeutics, Erasca, ReCode Therapeutics and 1 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Erasca investors are on Angel Roster?
Angel Roster lists 23 Erasca investors. 13 of them (57%) include a verified email address.
What types of investors are they?
The most common investor types are Private Equity Firms (18), Venture Capital Firms (16) and Finance Operator Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Erasca investors invest in?
Among those that list a stage, the most common are Series B (8), Series A (6) and Seed (5).
Where are Erasca investors based?
Most are based in the United States (19), Israel (2) and China (1).
Which companies have Erasca investors backed?
The most-backed portfolio companies among them are AnchorDx (19), Aspen Neuroscience (19), Silverback Therapeutics (12), ReCode Therapeutics (12) and ORIC Pharmaceuticals (11).
How do I contact Erasca investors?
Create a free Angel Roster account to search and filter all 23, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.